Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 4/2013

01-08-2013 | Original Article

Risk factors for recurrent cystitis following acute cystitis in female patients

Authors: Byung Il Yoon, Sun Wook Kim, U-Syn Ha, Dong Wan Sohn, Yong-Hyun Cho

Published in: Journal of Infection and Chemotherapy | Issue 4/2013

Login to get access

Abstract

We conducted a retrospective analysis of acute cystitis (AC) patients to evaluate the risk factors of recurrent cystitis (RC) patients following AC. The clinical records of 254 subjects with a confirmed diagnosis of AC and 90 healthy subjects who visited the Health Promotion Center between 2008 and 2012 were reviewed. A patient was diagnosed with RC if she was treated for three or more symptomatic episodes of cystitis over a 12-month period. Results were analyzed according to three groups: normal control (group A, n = 90), AC (group B, n = 121), and RC (group C, n = 133). Women in the cystitis groups (groups B and C) were more likely to have diabetes, be menopausal, have a history of catheterization or sexually transmitted infections (STI), have a low daily water intake, have frequent sexual intercourse, and to use contraception more frequently than the normal control group (P < 0.05). In groups B and C, Escherichia coli was the most common uropathogen, followed by Staphylococcus saprophyticus, Enterococcus species, and Klebsiella species. There were no differences between groups in the detection rates of these uropathogens. Factors that affected progression to RC were diabetes, catheterization history, STI history, sexual intercourse more than four times per month, sexual intercourse in the last month, and the use of contraceptives (P < 0.05). The identification of these factors may help develop preventive, diagnostic, and therapeutic strategies for treating RC that has progressed from AC.
Literature
1.
go back to reference Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents. 2001;17:343–8.PubMedCrossRef Ronald AR, Nicolle LE, Stamm E, Krieger J, Warren J, Schaeffer A, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents. 2001;17:343–8.PubMedCrossRef
2.
go back to reference Kunin CM. Urinary tract infections: detection, prevention, and management. Baltimore: Williams & Wilkins; 1997. Kunin CM. Urinary tract infections: detection, prevention, and management. Baltimore: Williams & Wilkins; 1997.
3.
go back to reference Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–15.PubMedCrossRef Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–15.PubMedCrossRef
4.
go back to reference Schappert SM, National Center for Health Statistics. National ambulatory medical care survey: 1992 summary. Hyattsville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Center for Disease Control and Prevention, National Center for Health Statistics; 1994. Schappert SM, National Center for Health Statistics. National ambulatory medical care survey: 1992 summary. Hyattsville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Center for Disease Control and Prevention, National Center for Health Statistics; 1994.
5.
go back to reference Mabeck CE. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med J. 1972;48:69–75.PubMedCrossRef Mabeck CE. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med J. 1972;48:69–75.PubMedCrossRef
6.
go back to reference Karram MM, Mallipeddi PK. Lower urinary tract infection. In: Walters MD, Karram MM, editors. Urogynecology and reconstructive pelvic surgery. 2nd ed. St. Louis: Mosby; 1999. p. 341–53. Karram MM, Mallipeddi PK. Lower urinary tract infection. In: Walters MD, Karram MM, editors. Urogynecology and reconstructive pelvic surgery. 2nd ed. St. Louis: Mosby; 1999. p. 341–53.
7.
go back to reference Hooton TM. Epidemiology. In: Stanton SL, Dwyer PL, editors. Urinary tract infection in the female. London: Martin Dunitz; 2000. p. 1–18. Hooton TM. Epidemiology. In: Stanton SL, Dwyer PL, editors. Urinary tract infection in the female. London: Martin Dunitz; 2000. p. 1–18.
8.
go back to reference O’Reilly M. Recurrent urinary tract infection. In: Stanton SL, Dwyer PL, editors. Urinary tract infection in the female. London: Martin Dunitz; 2000. p. 227–40. O’Reilly M. Recurrent urinary tract infection. In: Stanton SL, Dwyer PL, editors. Urinary tract infection in the female. London: Martin Dunitz; 2000. p. 227–40.
9.
go back to reference Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin N Am. 1997;11:551–81.CrossRef Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin N Am. 1997;11:551–81.CrossRef
10.
go back to reference Lee SJ, Lee DS, Choe HS, Shim BS, Kim CS, Kim ME, et al. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother. 2011;17:440–6.PubMedCrossRef Lee SJ, Lee DS, Choe HS, Shim BS, Kim CS, Kim ME, et al. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System. J Infect Chemother. 2011;17:440–6.PubMedCrossRef
11.
12.
go back to reference ACOG Practice Bulletin No. 91. Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111:785–94.CrossRef ACOG Practice Bulletin No. 91. Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111:785–94.CrossRef
13.
go back to reference Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 1998;282:1494–7.PubMedCrossRef Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science. 1998;282:1494–7.PubMedCrossRef
14.
go back to reference Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177–82.PubMedCrossRef Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177–82.PubMedCrossRef
15.
go back to reference Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22:91–9.PubMedCrossRef Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, et al. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis. 1996;22:91–9.PubMedCrossRef
16.
go back to reference Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151:1194–205.PubMedCrossRef Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151:1194–205.PubMedCrossRef
17.
go back to reference Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent UTI in young women. Clin Infect Dis. 1997;25:440. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent UTI in young women. Clin Infect Dis. 1997;25:440.
18.
go back to reference Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178:446–50.PubMedCrossRef Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis. 1998;178:446–50.PubMedCrossRef
19.
go back to reference Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol. 2010;184:564–9.PubMedCrossRef Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol. 2010;184:564–9.PubMedCrossRef
20.
go back to reference Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol. 2005;19:861–73.PubMedCrossRef Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol. 2005;19:861–73.PubMedCrossRef
21.
go back to reference Kodner CM. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician. 2010;82:638–43.PubMed Kodner CM. Recurrent urinary tract infections in women: diagnosis and management. Am Fam Physician. 2010;82:638–43.PubMed
22.
go back to reference Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56–64.PubMed Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians. 1956;69:56–64.PubMed
23.
go back to reference Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152–6.PubMedCrossRef Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152–6.PubMedCrossRef
24.
go back to reference Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol. 2004;171:768–70.PubMedCrossRef Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol. 2004;171:768–70.PubMedCrossRef
25.
go back to reference Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331–3.PubMedCrossRef Foxman B. Recurring urinary tract infection: incidence and risk factors. Am J Public Health. 1990;80:331–3.PubMedCrossRef
26.
go back to reference Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(suppl 1A):14S–9S.CrossRef Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(suppl 1A):14S–9S.CrossRef
Metadata
Title
Risk factors for recurrent cystitis following acute cystitis in female patients
Authors
Byung Il Yoon
Sun Wook Kim
U-Syn Ha
Dong Wan Sohn
Yong-Hyun Cho
Publication date
01-08-2013
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 4/2013
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-013-0556-2

Other articles of this Issue 4/2013

Journal of Infection and Chemotherapy 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.